Drug wholesalers oppose entry of Samsung Mulsan

Published: 2008-10-30 06:59:00

Updated: 2008-10-30 06:59:00

Korean pharmaceutical wholesalers are jittery over Samsung Mulsan’s move to advance into the local drug logistic business, claiming that the conglomerate will likely encroach on domestic drug distribution market.

Members of the Korean Association of Pharmaceutical Wholesaler said in a statemen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK